E., Tuccinardi, D., Lubrano, C., Gnessi, L., Isidori, A
6 In individuals with a history of chronic smoking, two-month supplementation with 250 mg twice daily improved hemogram, lipid profile, antioxidant status, and pulmonary function, alongside improvements in cough with expectoration, exertional dyspnea, palpitations, sleep quality, irritability, and fatigue
Since the early 1990s, when Roberts and Szabos cytoprotection concept had already been more than one decade old, but still not implemented in therapy, we suggest the stable gastric pentadecapeptide BPC 157 as the most relevant mediator of the cytoprotection concept.
The recent Childrens Oncology Group (COG) ARST0332 trial (which included MPNSTs) utilized the AJCC sixth edition staging system, which was current at the time of study inception